ARTIRIA Medical

Artiria Medical is a private, commercial-stage medical device company leveraging Swiss microengineering to address critical unmet needs in neurointerventional procedures. The company's core technology is the SmartGUIDE™, a 0.014-inch guidewire with a dynamically deflectable tip controlled via an intuitive handle, designed to navigate tortuous cerebral vasculature without pre-shaping. With FDA clearance and a CE Mark, Artiria is generating early revenue in the US and European markets, supported by initial clinical evidence and a focused team with expertise in robotics and medical devices. The company is positioned in the high-growth stroke intervention market, aiming to set a new standard of care.

Real-time, in-situ deflectable guidewire platform featuring an intuitive handle with incremental tip deflection control, designed for navigating tortuous cerebral vasculature.

Artiria competes in the neurovascular access device market, dominated by large-cap medical device companies like Medtronic, Stryker, and Johnson & Johnson (Cerenovus). Its primary differentiation is the real-time, controlled deflectability of its guidewire, a feature not commonly found in standard neuro guidewires. It competes on the basis of procedural efficiency and access success in complex anatomy, rather than cost.